Myeloma 2018 | Myeloma 2018 day 1 highlights: precision medicine, epigenetics & novel targets

Keith Stewart, Kenneth Anderson and Sagar Lonial

Keith Stewart, MB, ChB from the Mayo Clinic, Rochester, MN, is joined by Kenneth Anderson, MD, of the Dana-Farber Cancer Institute, Boston, MA, and Sagar Lonial, MD, of the Winship Cancer Institute of Emory University, Atlanta, GA, to share their highlights from day 1 of the Myeloma 2018 meeting, held in San Diego, CA. Hear their thoughts on precision medicine, immunotherapy, genomics, epigenetics, novel agents and more.

Share this video